|
5-[2-环丙基-1-(2-氟苯基)-2-氧代乙基]-5,6,7,7a-四氢噻吩并[3,2-c]吡啶-2(4H)-酮
|
||
| CAS: 150322-38-6 | 分子式: C18H18FNO2S | UN: - |
| HS: 29349990 |
中文别名:
去乙酰普拉格雷; 5-[2-环丙基-1-(2-氟苯基)-2-氧乙基]-5,6,7,7a-四氢噻吩并[3,2-c]吡啶-2(4H)-酮; 普拉格雷水解杂质; 普拉格雷中间体; 普拉格雷杂质A; 5-[2-环丙基-1-(2-氟苯基)-2-氧代乙基]-5,6,7,7-1-四氢噻吩并[3,2-C]吡啶-2(4H)-酮
|
|
|
(5S,6S,9R)-5-氨基-6-(2,3-二氟苯基)-6,7,8,9-四氢-5H-环庚[B]吡啶-9-醇二盐酸盐
|
||
| CAS: 1373116-07-4 | 分子式: C16H17ClF2N2O | UN: - |
| HS: - |
中文别名:
瑞美吉泮中间体;瑞美吉泮中间体9;瑞美吉泮杂质26;瑞美吉泮杂质24二盐酸盐;(5S,6S,9R)-5-胺基-6-(2,3-二氟苯基)-6,7,8,9-四氢-5H-环庚[B]吡啶-9-羟基二盐酸盐;瑞美吉泮杂质15二盐酸盐;(5S,6S,9R)-5-AMINO-Chemicalbook6-(2,3-DIFLUOROPHENYL)-6,7,8,9-TETRAHYDRO-5H-CYCLOHEPTA[B]PYRIDIN-9-OL2HCL(5S,6S,9R)-5-氨基-6-(2,3-二氟苯基)-6,7,8,9-四氢-5H-环庚[B]吡啶-9-醇二盐酸盐
|
|
|
(3R,4S)-4-[4-(苄氧基)苯基]-1-(4-氟苯基)-3-[3-(4-氟苯基)-3-氧代丙基]氮杂环丁烷-2-酮
|
||
| CAS: 190595-65-4 | 分子式: C31H25F2NO3 | UN: - |
| HS: 29339900 |
中文别名:
1-(4氟苯基)-3-[3-氧代-3-(4氟苯基)丙基]-4-(4苄氧苯基)-2-氮杂环丁酮; (3R,4S)-1-(4-氟苯)-3-[3-(4-氟苯-3-氧基丙基]-4-[4-(苯甲氧基)苯基],2-氮杂环丁酮; 依泽替米贝中间体1; 苄基依折麦布酮; 依折麦布中间体; (3R,4S)-4-[4-(苄氧基)苯基]-1-(4-氟苯基)-3-[3-(4-氟苯基)-3-氧代丙基]氮杂啶-2-酮; (3R,4S)-1-(4-氟苯基)-3(R)-［3-(4-氟苯基)-3(S)-羰基丙基］-4(S)-(4-卞氧苯基)-2-氮杂环丁酮; 依折麦布杂质
|
|
|
(3S-顺式)-4-氯苯磺酸[5-(2,4-二氟苯基)四氢-5-(1H-1,2,4-三唑-1-基甲基)-3-呋喃基]甲基酯
|
||
| CAS: 175712-02-4 | 分子式: C20H18ClF2N3O4S | UN: - |
| HS: 29349990 |
中文别名:
泊沙康唑主环
|
|
|
(5R-cis)-甲苯-4-磺酸 5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基)甲基四氢呋喃-3-基甲基酯
|
||
| CAS: 149809-43-8 | 分子式: C21H21F2N3O4S | UN: - |
| HS: 29349990 |
中文别名:
((3R,5R)-5-((1H-1,2,4-三氮唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基4-甲基苯磺酸盐; 泊沙康唑-1; 泊沙康唑中间体12; 泊沙康唑主环; 泊沙主环; ((3R,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基4-甲基苯磺酸酯; (5R-顺式)-甲苯-4-磺酸5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基)甲基四氢呋喃-3-基甲基酯; (2R-顺)-2-(2,4 -二氟苯基)-4 - [[(4 -甲基苯基)磺酰氧基]甲 基]-2-[(1H-1,2,4-三唑-1-基)甲基]四氢呋喃; (5R,3S)-甲苯-4-磺酸-5-(2,4-二氟-苯基)-5-[1,2,4]三唑基-1-甲基-四氢呋喃-3-甲基酯; 对甲基苯磺酸(3S,5R)-5-(2,4-二氟苯基)-5-[(1H-1,2,4-三唑-1-基)甲基]恶烷-3-基甲酯
|
|
|
((3S,5S,6R)-6-甲基-2-氧代-1-(2,2,2-三氟乙基)-5-(2,3,6-三氟苯基)哌啶-3-基)氨基甲酸叔丁酯
|
||
| CAS: 1375471-12-7 | 分子式: C19H22F6N2O3 | UN: - |
| HS: - |
中文别名:
-
|
|
|
(2R,3S/2S,3R)-2-(2,4-二氟苯基)-3-(5-氟嘧啶-4-基)-1-(1H-1,2,4-三唑- 1-基)-2-丁醇
|
||
| CAS: 182230-43-9 | 分子式: C16H14F3N5O | UN: - |
| HS: 29339900 |
中文别名:
伏立康唑杂质A; 伏立康唑异构体; 伏立康唑USP相关化合物A
|
|
|
(4R,6S)-6-[[(1E)-2-环丙基-4-(4-氟苯基)-3-喹啉基]乙烯基]-2,2-二甲基-1,3-二氧六环-4-乙酸叔丁酯
|
||
| CAS: 147489-06-3 | 分子式: C32H36FNO4 | UN: - |
| HS: 29349990 |
中文别名:
6-[[(1E)-2-环丙基-4-(4-氟苯基)-3-喹啉基]-乙烯基]-2,2-二甲基-1,3-二氧六环-4-乙酸叔丁酯
|
|
|
(2R,3S/2S,3R)-3-(6-氯-5-氟嘧啶-4-基)-2-(2,4-二氟苯基)-1-(1H-1,2,4-三唑-1-基)-2-丁醇盐酸盐
|
||
| CAS: 188416-35-5 | 分子式: C16H13ClF3N5O | UN: - |
| HS: 2933 5990 |
中文别名:
2S,3R)-3-(6-氯-5-氟嘧啶-4-基)-2-(2,4-二氟苯基)-1-(1H-1,2,4-三唑-1-基)-2-丁醇盐酸盐; (2R,3S/2S,3R)-3-(6-氯-5-氟嘧啶-4-基)-2-(2,4-二氟苯基)-1-(1H-1,2,4-三唑-1-基)-2-丁醇; 伏立康唑中间体一; 3-(6-氯-5-氟嘧啶-4-基)-2-(2,4-二氟苯基)-1-(1H-1,2,4-三唑-1-基)-2-丁醇; ②(2R,3S/2S,3R)-3-(6-氯-5-氟嘧啶-4-基)-2-(2,4-二氟苯基)--(H-,2,4-三唑--基)-2-丁醇盐酸盐; (2R,3S/2S,3R)-3-(4-氯-5-氟-6-嘧啶基)-2-(2,4-二氟苯基)-1-(1H-1,2,4-三唑-1-基)-2-丁醇盐酸盐
|
|
|
6-[(1E)-2-[4-(4-氟苯基)-6-异丙基-2-[甲基(甲磺酰)氨基]-5-嘧啶]乙烯基]-2,2-二甲基-1,3-二氧六环-4-乙酸叔丁酯
|
||
| CAS: 289042-12-2 | 分子式: C29H40FN3O6S | UN: - |
| HS: 29359000 |
中文别名:
6-[(1E)-2-[4-(4-氟苯基)-6-异丙基-2-[甲基(甲磺酰)氨基]-5-嘧啶]乙烯基]; 瑞舒伐他汀对接物; 7 R-2 6-[(E)-2-[4-(4-氟苯基)-6-异丙基-2-[甲基(甲磺酰)氨基]-5-嘧啶]乙烯基]-2,2-二甲基-1,3-二氧六环-4-乙酸叔丁酯; 罗素伐他汀钙中间体 R-2
|
|
没有找到你想要的吗？发布采购请求并快速获取报价
RFQ
询价单
登录
登录失败！
b
Thank You！
Your requirement has been sent, we will contact you quickly!
Sent Failed！
Try again!
发送邮件
发送中...
Thank You！
Your requirement has been sent, we will contact you quickly!
Sent Failed！
Try again!